1[2] Aylward B., Lioyd J, zaffran M, et al, Reducing the risk of unsafe injection in immunization program: financial and oprational implications of various injection technologies. Bull. of the WHO, 1995, 73(4):531-540.
2[3] Hu DJ, Kane MA, Heymann DL. Transmission of HIV, hepatitis B virus and other blood-borne pathogen in health care setting: a review of risk factors and guidelines for prevention. Bull World Hcalth Organ, 1991, 69 (5):623-630.
3[4] Soeters R, Aus C. Hazards of injectable therapy. Trop Doct, 1989, 19 (3):124-126.
4[5] Aylward B, Kane M, McNair-Scott R, et al. Model-Based Estimates of the Risk of Human Immunodeficiency Virus and Hepatitis B Virus Transmission through Unsafe Injections. International Journal of Epidemiology, 1995, 24(2): 446-452.
5[6] Craig N. Shapiro, Occupatioonal Risk of injection with Hepatitis B and Hepatitis C virus. Surgical Clinic of North America, 1995, 75(6):1 056-1 057.
6[7] UNICEF. Fielden Battersby Analysts, Choosing a sustainable Policy for Giving Safe Injection in Romania, Final Report, October 1993.
7[8] Ko YC, Li SC, Yen YY, et al. Horizontal Transmission of Hepatitis B Virus from Siblings and Intermuscular Injection among Preschool Children in A Familial Cohort. Am J Epidemiol, 1991, 133(10): 1 015-1 023.
8[9] Hutin J F Y, Herpaz R, Drobeniuc J, et al. Injections Given in Healthcare setting as A Major Source of Acute Hepatitis B in Moldova. Int. J. Epidemiol, 1999, 28(4): 782-786.
10[11] Zaffran M., Lloyd J, et al. Clements J., A drive to safe injections. Scientific Advisory Group of Experts (SAGE),`WHO, Geneva, 1997, June 11-13.
4Shanghai Municipal Electric Power Company(Shanghai Municipal Electric Power Company, Shanghai 200122, China).有效实施需求侧管理 确保上海均衡有序用电[J].华东电力,2005,33(6):1-3. 被引量：1
